WLLW

Willow Biosciences (WLLW)

Willow Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:TSX:WLLW

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/13	20:00	PR Newswire (US)	WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE	TSX:WLLW	Willow Biosciences Inc
2024/05/13	20:00	PR Newswire (Canada)	WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE	TSX:WLLW	Willow Biosciences Inc
2024/03/29	08:30	PR Newswire (Canada)	WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF	TSX:WLLW	Willow Biosciences Inc
2024/03/29	08:30	PR Newswire (US)	WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF	TSX:WLLW	Willow Biosciences Inc
2024/03/01	08:00	PR Newswire (US)	WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSEC	TSX:WLLW	Willow Biosciences Inc
2024/03/01	08:00	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSEC	TSX:WLLW	Willow Biosciences Inc
2024/02/21	08:00	PR Newswire (US)	WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
2024/02/21	08:00	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
2024/01/31	21:00	PR Newswire (US)	WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT	TSX:WLLW	Willow Biosciences Inc
2024/01/31	21:00	PR Newswire (Canada)	WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT	TSX:WLLW	Willow Biosciences Inc
2024/01/16	21:00	PR Newswire (US)	WILLOW ANNOUNCES COLLABORATION WITH ENTERIN TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
2024/01/16	21:00	PR Newswire (Canada)	WILLOW ANNOUNCES COLLABORATION WITH ENTERIN TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
2024/01/10	21:00	PR Newswire (US)	WILLOW PLANS FOR SIGNIFICANT GROWTH IN 2024 ON THE BACK OF A SUCCESSFUL 2023	TSX:WLLW	Willow Biosciences Inc
2024/01/10	21:00	PR Newswire (Canada)	WILLOW PLANS FOR SIGNIFICANT GROWTH IN 2024 ON THE BACK OF A SUCCESSFUL 2023	TSX:WLLW	Willow Biosciences Inc
2023/12/07	21:00	PR Newswire (US)	WILLOW AND LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY ADVANCE DEVELOPMENT PROGRAM TO MANUFACTURE SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
2023/12/07	21:00	PR Newswire (Canada)	WILLOW AND LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY ADVANCE DEVELOPMENT PROGRAM TO MANUFACTURE SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
2023/10/11	08:52	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES COMPLETION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCING	TSX:WLLW	Willow Biosciences Inc
2023/10/11	08:52	PR Newswire (US)	WILLOW BIOSCIENCES ANNOUNCES COMPLETION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCING	TSX:WLLW	Willow Biosciences Inc
2023/10/03	20:00	PR Newswire (US)	WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATION	TSX:WLLW	Willow Biosciences Inc
2023/10/03	20:00	PR Newswire (Canada)	WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATION	TSX:WLLW	Willow Biosciences Inc
2023/10/03	16:00	PR Newswire (US)	WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATION	TSX:WLLW	Willow Biosciences Inc
2023/09/12	20:00	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES COMPANY INSIDER LED CONVERTIBLE DEBENTURE FINANCING	TSX:WLLW	Willow Biosciences Inc
2023/09/06	20:00	PR Newswire (Canada)	WILLOW ANNOUNCES SUCCESSFUL COMPLETION OF R&D PROGRAM ON COST-EFFECTIVE, SUSTAINABLY PRODUCED UDCA	TSX:WLLW	Willow Biosciences Inc
2023/09/06	20:00	PR Newswire (US)	WILLOW ANNOUNCES SUCCESSFUL COMPLETION OF R&D PROGRAM ON COST-EFFECTIVE, SUSTAINABLY PRODUCED UDCA	TSX:WLLW	Willow Biosciences Inc
2023/08/30	20:00	PR Newswire (US)	WILLOW ANNOUNCES FILING OF PATENT APPLICATION FOR PROCESS TO PRODUCE CORTICOSTEROIDS AT SIGNFICANTLY REDUCED COST	TSX:WLLW	Willow Biosciences Inc
2023/08/30	20:00	PR Newswire (Canada)	WILLOW ANNOUNCES FILING OF PATENT APPLICATION FOR PROCESS TO PRODUCE CORTICOSTEROIDS AT SIGNFICANTLY REDUCED COST	TSX:WLLW	Willow Biosciences Inc
2023/08/24	20:00	PR Newswire (US)	WILLOW BIOSCIENCES ANNOUNCES COMMERCIAL TRANSITION AND FOCUS ON BIOOXI PLATFORM	TSX:WLLW	Willow Biosciences Inc
2023/08/24	20:00	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES COMMERCIAL TRANSITION AND FOCUS ON BIOOXI PLATFORM	TSX:WLLW	Willow Biosciences Inc
2023/08/21	20:00	PR Newswire (US)	WILLOW ANNOUNCES COLLABORATION WITH A LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
2023/08/21	20:00	PR Newswire (Canada)	WILLOW ANNOUNCES COLLABORATION WITH A LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS	TSX:WLLW	Willow Biosciences Inc